Ottobock SE & Co. KGaA (FRA:OBC)

Market Cap	3.15B -26.5%
Revenue (ttm)	1.73B +5.5%
Net Income	128.60M +122.1%
EPS	0.41 +118.7%
Shares Out	n/a
PE Ratio	22.17
Forward PE	14.84
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100
Open	9.04
Previous Close	9.02
Day's Range	8.98 - 9.06
52-Week Range	8.84 - 12.35
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Ottobock SE & Co. KGaA

Ottobock SE & Co. KGaA develops, produces, and distributes medical technology products and components for the people with disabilities in the fields of prosthetics, orthotics, human mobility, and industrial exoskeletons in Europe, the Middle East, Africa, North and South America, and the Asia Pacific. The company is involved in identification, development, manufacturing, sales, and marketing of prosthetics, neuro-orthotics, and digital solutions; prostheses for the upper and lower extremities; mechanical prostheses and technologically sophistic...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1919
• Employees: 9,406
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: OBC

Financial Performance

In 2025, Ottobock SE & Co. KGaA's revenue was 1.68 billion, an increase of 4.69% compared to the previous year's 1.60 billion. Earnings were 90.20 million, an increase of 198.68%.

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 23, 2026

Data Sources Report a data error